Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition

LEGN 11.07.2024

Full Press ReleaseSEC FilingsOur LEGN Tweets

About Gravity Analytica

Recent News

  • 01.14.2025 - 43rd Annual JP Morgan Healthcare Conference
  • 12.19.2024 - Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference
  • 12.10.2024 - CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma

Recent Filings

  • 01.22.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
  • 01.14.2025 - EX-99.1 EX-99.1
  • 01.10.2025 - 144 Report of proposed sale of securities

SOMERSET, N.J.,Nov. 07, 2024(GLOBE NEWSWIRE) --Legend Biotech Corporation(NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors onSunday, December 8, 2024, at8:00 p.m. PT(11:00 p.m. ET) during the 66thAmerican Society of Hematology(ASH) Annual Meeting and Exposition inSan Diego, CA.

During the webcast,Ying Huang, Ph.D., Chief Executive Officer, andMythili Koneru, M.D., Ph.D., Chief Medical Officer, will host expert clinicians as they review the latest updates from the CARTITUDE development program.

Investors and other interested parties may join the live webcast through thisweblinkor by visiting Legend Biotech’s website underEvents and Presentation.

AboutLegend BiotechLegend Biotechis a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered inSomerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.

Learn more atwww.legendbiotech.comand follow us onX (formerly Twitter)andLinkedIn.

INVESTOR CONTACT:Jessie YeungTel: (732) 956-8271jessie.yeung@legendbiotech.com

PRESS CONTACT:Mary Ann OndishTel: (914) 552-4625media@legendbiotech.com

Primary Logo

Source: Legend Biotech USA Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com